Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1764292

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1764292

Continuous Glucose Monitoring Global Market Report 2025

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Continuous glucose monitoring (CGM) is a medical technology that continuously measures glucose levels in real time throughout the day and night using a small sensor placed under the skin. It assists people with diabetes in managing their condition by providing ongoing data and alerts for high or low blood sugar levels.

The key components of continuous glucose monitoring systems include transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one point to another for communication or control. These systems are utilized by both adults and children and cater to a range of end users, including hospitals, home care environments, diagnostic centers, clinics, and other healthcare facilities.

The continuous glucose monitoring market research report is one of a series of new reports from The Business Research Company that cover continuous glucose monitoring market statistics, including the continuous glucose monitoring industry's global market size, regional shares, competitors with the continuous glucose monitoring market share, detailed continuous glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring market. This continuous glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $8.20 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%./b> The growth during the historic period can be attributed to the rising prevalence of diabetes, increasing awareness of diabetes management, growing demand for real-time glucose monitoring, greater adoption of minimally invasive technologies, and higher healthcare spending in developed nations.

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $16.45 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%./b> The growth in the forecast period can be attributed to the increasing emphasis on personalized and precision medicine, the rising adoption of telehealth and remote patient monitoring, an enhanced focus on preventive healthcare and early diagnosis, greater preference for home-based glucose monitoring, and expanding market penetration in emerging regions. Key trends during the forecast period include miniaturization of implantable devices, development of closed-loop insulin delivery systems, integration with electronic health records, compatibility with fitness trackers and smartwatches, and advancements in skin-adhesive materials.

The increasing prevalence of diabetes is expected to drive the growth of the continuous glucose monitoring market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar (glucose) levels. This rise in diabetes cases is mainly due to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring supports diabetes management by providing real-time blood sugar trends, allowing timely adjustments to diet, medication, and physical activity for better glucose control. For example, in November 2023, the American Diabetes Association, a U.S.-based non-profit organization, reported that in 2022, approximately 25.5 million people in the U.S.-about 7.6% of the population-were diagnosed with diabetes, marking a 3% increase compared to previous years. Thus, the rising prevalence of diabetes is fueling growth in the continuous glucose monitoring market.

Leading companies in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to improve accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors continuously measure blood sugar levels using a small sensor inserted under the skin. For example, in August 2024, DexCom, Inc., a U.S.-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings via a small sensor worn on the back of the upper arm, sending data directly to a smartphone without the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand how factors such as diet, exercise, and sleep affect their glucose levels, enabling smarter lifestyle decisions. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not using insulin, those with prediabetes, or anyone monitoring their glucose health.

In September 2023, Abbott Laboratories, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed sum. Through this acquisition, Abbott seeks to strengthen its position in diabetes care by enhancing its Freestyle Libre continuous glucose monitoring technology and advancing connected solutions to make diabetes management more personalized and precise. Bigfoot Biomedical Inc., also based in the U.S., is a medical technology company that provides a diabetes management system integrating continuous glucose monitoring (CGM) technology.

Major players in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Texas Instruments Inc., Microchip Technology Inc., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Zillion Technologies Inc., Bionime Corporation, Biolinq Inc., Beta Bionics Inc., AgaMatrix Inc., A. Menarini Diagnostics S.r.l, Senseonics Holdings Inc., Medtrum Technologies Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Transmitters; Sensors; Receivers
  • 2) By Age Group: Adults; Children
  • 3) By End Use: Hospitals; Home Care Settings; Diagnostic Centers And Clinics; Other End Uses
  • Subsegments:
  • 1) By Transmitters: Reusable Transmitters; Disposable Transmitters; Rechargeable Transmitters
  • 2) By Sensors: Implantable Sensors; Transcutaneous Sensors; Disposable Sensors; Real-Time Sensors
  • 3) By Receivers: Standalone Receivers; Integrated Receivers; Wearable Display Devices
  • Companies Mentioned: Roche Diabetes Care; Abbott Laboratories; Medtronic plc; Texas Instruments Inc.; Microchip Technology Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r35880

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Market Characteristics

3. Continuous Glucose Monitoring Market Trends And Strategies

4. Continuous Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Continuous Glucose Monitoring Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Glucose Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Glucose Monitoring Market Growth Rate Analysis
  • 5.4. Global Continuous Glucose Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Glucose Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Glucose Monitoring Total Addressable Market (TAM)

6. Continuous Glucose Monitoring Market Segmentation

  • 6.1. Global Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transmitters
  • Sensors
  • Receivers
  • 6.2. Global Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Children
  • 6.3. Global Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Home Care Settings
  • Diagnostic Centers And Clinics
  • Other End Uses
  • 6.4. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reusable Transmitters
  • Disposable Transmitters
  • Rechargeable Transmitters
  • 6.5. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Sensors
  • Transcutaneous Sensors
  • Disposable Sensors
  • Real-Time Sensors
  • 6.6. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standalone Receivers
  • Integrated Receivers
  • Wearable Display Devices

7. Continuous Glucose Monitoring Market Regional And Country Analysis

  • 7.1. Global Continuous Glucose Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Glucose Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Glucose Monitoring Market

  • 8.1. Asia-Pacific Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Glucose Monitoring Market

  • 9.1. China Continuous Glucose Monitoring Market Overview
  • 9.2. China Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Glucose Monitoring Market

  • 10.1. India Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Glucose Monitoring Market

  • 11.1. Japan Continuous Glucose Monitoring Market Overview
  • 11.2. Japan Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Glucose Monitoring Market

  • 12.1. Australia Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Glucose Monitoring Market

  • 13.1. Indonesia Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Glucose Monitoring Market

  • 14.1. South Korea Continuous Glucose Monitoring Market Overview
  • 14.2. South Korea Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Glucose Monitoring Market

  • 15.1. Western Europe Continuous Glucose Monitoring Market Overview
  • 15.2. Western Europe Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Glucose Monitoring Market

  • 16.1. UK Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Glucose Monitoring Market

  • 17.1. Germany Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Glucose Monitoring Market

  • 18.1. France Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Glucose Monitoring Market

  • 19.1. Italy Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Glucose Monitoring Market

  • 20.1. Spain Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Glucose Monitoring Market

  • 21.1. Eastern Europe Continuous Glucose Monitoring Market Overview
  • 21.2. Eastern Europe Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Glucose Monitoring Market

  • 22.1. Russia Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Glucose Monitoring Market

  • 23.1. North America Continuous Glucose Monitoring Market Overview
  • 23.2. North America Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Glucose Monitoring Market

  • 24.1. USA Continuous Glucose Monitoring Market Overview
  • 24.2. USA Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Glucose Monitoring Market

  • 25.1. Canada Continuous Glucose Monitoring Market Overview
  • 25.2. Canada Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Glucose Monitoring Market

  • 26.1. South America Continuous Glucose Monitoring Market Overview
  • 26.2. South America Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Glucose Monitoring Market

  • 27.1. Brazil Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Glucose Monitoring Market

  • 28.1. Middle East Continuous Glucose Monitoring Market Overview
  • 28.2. Middle East Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Glucose Monitoring Market

  • 29.1. Africa Continuous Glucose Monitoring Market Overview
  • 29.2. Africa Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Glucose Monitoring Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Glucose Monitoring Market Competitive Landscape
  • 30.2. Continuous Glucose Monitoring Market Company Profiles
    • 30.2.1. Roche Diabetes Care Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Texas Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Microchip Technology Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Glucose Monitoring Market Other Major And Innovative Companies

  • 31.1. Dexcom Inc.
  • 31.2. Insulet Corporation
  • 31.3. Tandem Diabetes Care Inc.
  • 31.4. Ypsomed AG
  • 31.5. Nova Biomedical
  • 31.6. Ascensia Diabetes Care
  • 31.7. Zillion Technologies Inc.
  • 31.8. Bionime Corporation
  • 31.9. Biolinq Inc.
  • 31.10. Beta Bionics Inc.
  • 31.11. AgaMatrix Inc.
  • 31.12. A. Menarini Diagnostics S.r.l
  • 31.13. Senseonics Holdings Inc.
  • 31.14. Medtrum Technologies Inc.
  • 31.15. Nemaura Medical Inc.

32. Global Continuous Glucose Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Market

34. Recent Developments In The Continuous Glucose Monitoring Market

35. Continuous Glucose Monitoring Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Glucose Monitoring Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Glucose Monitoring Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Glucose Monitoring Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!